Frontiers in Immunology (Nov 2021)

The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer

  • Laura García-Estevez,
  • Laura García-Estevez,
  • Laura García-Estevez,
  • Silvia González-Martínez,
  • Silvia González-Martínez,
  • Gema Moreno-Bueno,
  • Gema Moreno-Bueno,
  • Gema Moreno-Bueno

DOI
https://doi.org/10.3389/fimmu.2021.784823
Journal volume & issue
Vol. 12

Abstract

Read online

Adipose tissue secretes various peptides, including leptin. This hormone acts through the leptin receptor (Ob-R), which is expressed ubiquitously on the surface of various cells, including breast cancer cells and immune cells. Increasing evidence points to an interaction between the tumor microenvironment, tumor cells, and the immune system. Leptin plays an important role in breast cancer tumorigenesis and may be implicated in activation of the immune system. While breast cancer cannot be considered an immunogenic cancer, the triple-negative subtype is an exception. Specific immune cells - tumor infiltrating lymphocytes - are involved in the immune response and act as predictive and prognostic factors in certain breast cancer subtypes. The aim of this article is to review the interaction between adipose tissue, through the expression of leptin and its receptor, and the adaptive immune system in breast cancer.

Keywords